Sitong Qian

Publications by Year

Research Areas

Liver Disease Diagnosis and Treatment, Chronic Kidney Disease and Diabetes, Hippo pathway signaling and YAP/TAZ, Lipid metabolism and disorders, Prostate Cancer Treatment and Research

Most-Cited Works

• → Amelioration of non-alcoholic fatty liver disease by sodium butyrate is linked to the modulation of intestinal tight junctions in db/db mice(2020)59 cited
• → Targeting mTOR/YY1 signaling pathway by quercetin through CYP7A1-mediated cholesterol-to-bile acids conversion alleviated type 2 diabetes mellitus induced hepatic lipid accumulation(2023)52 cited
• → Targeting mammalian serine/threonine-protein kinase 4 through Yes-associated protein/TEA domain transcription factor-mediated epithelial-mesenchymal transition ameliorates diabetic nephropathy orchestrated renal fibrosis(2020)51 cited
• → Zebrafish xenograft model for studying mechanism and treatment of non-small cell lung cancer brain metastasis(2021)31 cited
• → Insulin exacerbated high glucose-induced epithelial-mesenchymal transition in prostatic epithelial cells BPH-1 and prostate cancer cells PC-3 via MEK/ERK signaling pathway(2020)26 cited
• → YY1 inactivated transcription co-regulator PGC-1α to promote mitochondrial dysfunction of early diabetic nephropathy-associated tubulointerstitial fibrosis(2022)22 cited
• → YY1 was indispensable for the alleviation of quercetin on diabetic nephropathy-associated tubulointerstitial inflammation(2023)21 cited
• → Jujuboside A through YY1/CYP2E1 signaling alleviated type 2 diabetes-associated fatty liver disease by ameliorating hepatic lipid accumulation, inflammation, and oxidative stress(2024)18 cited
• → Sirt1-mediated deacetylation of PGC-1α alleviated hepatic steatosis in type 2 diabetes mellitus via improving mitochondrial fatty acid oxidation(2024)16 cited
• → The synergistic effects of PRDX5 and Nrf2 on lung cancer progression and drug resistance under oxidative stress in the zebrafish models(2022)14 cited